F2 CoV-2-IG study

The CoV-2-IG study ifocuses on the analysis of seroprevalence in the population of healthcare workers. The objectives concern the validation of the serological test and the serological differences depending on the different levels of exposure to the virus in the hospitals involved. The study involves 5000 health workers; the results of the seroprevalence are analyzed on the basis of the differences in the risk of exposure, in relation to individual sites, departments and different professions (e.g. medical staff vs. administrative).